Table 2.
Primary and secondary outcome of patients with acute appendicitis during the study period 2020 and the combined control period 2018–2019.
| 2020 | 2019–2018 | p | |
|---|---|---|---|
| n = 176 | n = 338 | ||
| Operation on … | |||
| … admission day | 118 (67.0%) | 185 (54.7%) | 0.0081a |
| … day after admission | 43 (24.4%) | 133 (39.3%) | |
| … 2 days or more after admission | 15 (8.5%) | 20 (5.9%) | |
| Severity of appendicitis | |||
| Perforated | 49 (27.8%) | 70 (20.7%) | 0.035b |
| Acute/phlegmonous to gangrenous (non-perf.) | 119 (67.6%) | 252 (74.6%) | |
| Negative/subacute | 6 (3.4%) | 13 (3.8%) | |
| Other finding | 2 (1.1%) | 3 (0.9%) | |
| Laparoscopic to open surgery conversion rate | 3 (1.7%) | 3 (0.9%) | 0.42a |
| Mean length of stay (d) Range (d) |
5.3 2–17 |
4.9 2–20 |
0.07a |
| Antibiotics given (%) | 145 (82.4%) | 279 (82.5%) | >0.99a |
|
If so, length of AB therapy (d) Range (d) |
4.4 1–15 |
3.8 1–45 |
|
| Reoperations (%) | 4 (2.2%) | 6 (1.8%) | 0.74a |
a
Fisher's exact test.
b
Cochran-Mantel-Haenszel-test.
Bold indicate to highlight statistically significant differences. Italics indicate to show these lines are subitems to the lines before.